Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Glioblastoma (GBM) is a highly aggressive glioma with an extremely poor prognosis after conventional treatment. Recent advances in immunotherapy offer hope for these patients with incurable GBM. Our present review aimed to provide an overview of immunotherapy for GBM, especially chimeric antigen rec...

Full description

Bibliographic Details
Main Authors:	Long Li, Xiqun Zhu, Yu Qian, Xiangling Yuan, Yi Ding, Desheng Hu, Xin He, Yuan Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-11-01
Series:	Frontiers in Immunology
Subjects:	glioblastoma brain tumor immunotherapy chimeric antigen receptor T cell therapy CAR T
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.594271/full

Similar Items

Challenges in the Treatment of Glioblastoma by Chimeric Antigen Receptor T-Cell Immunotherapy and Possible Solutions
by: Peng Zhang, et al.
Published: (2022-07-01)

Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma
by: Rebecca C Abbott, et al.
Published: (2023-01-01)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
by: Rebecca C Abbott, et al.
Published: (2021-01-01)

Immunotherapy of glioblastoma: Recent advances and future prospects
by: Boyang Yuan, et al.
Published: (2022-11-01)

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors: The Past and the Future
by: Samer A. Srour, et al.
Published: (2023-01-01)

Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
by: Hany E. Marei, et al.
Published: (2021-08-01)

The Chimeric Antigen Receptor Detection Toolkit
by: Yifei Hu, et al.
Published: (2020-08-01)

Clinical chimeric antigen receptor‐T cell therapy: a new and promising treatment modality for glioblastoma
by: Michael P Brown, et al.
Published: (2019-01-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
by: Stefan Stoiber, et al.
Published: (2019-05-01)

Paving the Way toward Successful Multiple Myeloma Treatment: Chimeric Antigen Receptor T-Cell Therapy
by: Ewelina Grywalska, et al.
Published: (2020-04-01)

Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by: Hamid R. Mirzaei, et al.
Published: (2017-12-01)

Novel mesothelin-targeted chimeric antigen receptor-modified UNKT cells are highly effective in inhibiting tumor progression
by: Wei Jiang, et al.
Published: (2023-11-01)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
by: Piotr Celichowski, et al.
Published: (2023-03-01)

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
by: Giuseppe Schepisi, et al.
Published: (2020-09-01)

Current and Future Perspectives for Chimeric Antigen Receptor T Cells Development in Poland
by: Tomasz J. Ślebioda, et al.
Published: (2022-11-01)

Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
by: Gianna M. Branella, et al.
Published: (2021-12-01)

Chimeric Antigen Receptor T Cells in Glioblastoma—Current Concepts and Promising Future
by: Rebecca Kringel, et al.
Published: (2023-07-01)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
by: Wenwen Wei, et al.
Published: (2022-11-01)

Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope
by: Jiajie Jing, et al.
Published: (2024-08-01)

The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook
by: Hao Zhang, et al.
Published: (2022-07-01)

Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer
by: Ke-Tao Jin, et al.
Published: (2021-02-01)

The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
by: Elaine Tan Su Yin, et al.
Published: (2022-06-01)

Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence
by: Agata Czaplicka, et al.
Published: (2024-01-01)

EphA2 specific chimeric antigen receptor engineered T cells for the treatment of prostate cancer
by: Miaomiao Zhang, et al.
Published: (2024-12-01)

Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023
by: Ming-Yao Sun, et al.
Published: (2023-08-01)

Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
by: Xiaorui Li, et al.
Published: (2021-08-01)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
by: Zakaria Grada, et al.
Published: (2013-01-01)

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy
by: Anja Feldmann, et al.
Published: (2020-01-01)

Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
by: Lauren C. Fleischer, et al.
Published: (2020-09-01)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
by: Ernesto Lopez, et al.
Published: (2023-12-01)

A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse
by: Stacie Shiqi Wang, et al.
Published: (2021-12-01)

The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy
by: Maria-Luisa Schubert, et al.
Published: (2021-05-01)

Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
by: Roa Alsajjan, et al.
Published: (2023-09-01)

T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
by: Dong Yang, et al.
Published: (2019-07-01)

Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis
by: Lijia Ou, et al.
Published: (2023-12-01)

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
by: Ali Keshavarz, et al.
Published: (2022-09-01)

Universal chimeric antigen receptor T cell therapy — The future of cell therapy: A review providing clinical evidence
by: Wenxuan Sun, et al.
Published: (2022-01-01)

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor
by: Mahmoud Hassani, et al.
Published: (2020-03-01)